These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3963032)

  • 1. Investigation of the abuse liability of buspirone in alcohol-dependent patients.
    Griffith JD; Jasinski DR; Casten GP; McKinney GR
    Am J Med; 1986 Mar; 80(3B):30-5. PubMed ID: 3963032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of buspirone and diazepam, alone and in combination with alcohol, on skilled performance and evoked potentials.
    Erwin CW; Linnoila M; Hartwell J; Erwin A; Guthrie S
    J Clin Psychopharmacol; 1986 Aug; 6(4):199-209. PubMed ID: 3734141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects.
    Jasinski DR; Preston KL
    Drug Alcohol Depend; 1986 May; 17(1):1-13. PubMed ID: 3720527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective and behavioral effects of diazepam depend on its rate of onset.
    de Wit H; Dudish S; Ambre J
    Psychopharmacology (Berl); 1993; 112(2-3):324-30. PubMed ID: 7871037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose pharmacodynamics of diazepam and pentobarbital in substance abusers.
    Sullivan JT; Jasinski DR; Johnson RE
    Clin Pharmacol Ther; 1993 Dec; 54(6):645-53. PubMed ID: 8275619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of buspirone and diazepam on objective and subjective tests of performance in healthy volunteers.
    Mattila M; Seppälä T; Mattila MJ
    Clin Pharmacol Ther; 1986 Dec; 40(6):620-6. PubMed ID: 3780124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal.
    Jaffe JH; Ciraulo DA; Nies A; Dixon RB; Monroe LL
    Clin Pharmacol Ther; 1983 Nov; 34(5):623-30. PubMed ID: 6627822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of diazepam and buspirone on subjective feelings, psychological tests and the EEG.
    Bond AJ; Lader MH
    Int Pharmacopsychiatry; 1981; 16(4):212-20. PubMed ID: 6121766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
    Orzack MH; Friedman L; Dessain E; Bird M; Beake B; McEachern J; Cole JO
    Int J Addict; 1988 May; 23(5):449-67. PubMed ID: 3061941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of diazepam and buspirone in normal volunteers.
    Rush CR; Critchfield TS; Troisi JR; Griffiths RR
    J Exp Anal Behav; 1995 May; 63(3):277-94. PubMed ID: 7751833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion: clinical assay for amphetamine-like abuse potential.
    Griffith JD; Carranza J; Griffith C; Miller LL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):206-8. PubMed ID: 6406459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG.
    Bond A; Lader M; Shrotriya R
    Eur J Clin Pharmacol; 1983; 24(4):463-7. PubMed ID: 6134624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronically administered buspirone and diazepam on driving-related skills performance.
    Moskowitz H; Smiley A
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):45-55. PubMed ID: 6130073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pharmacology and abuse potential of meptazinol.
    Johnson RE; Jasinski DR
    Clin Pharmacol Ther; 1987 Apr; 41(4):426-33. PubMed ID: 3829579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the abuse potential of pagoclone, a partial GABAA agonist.
    de Wit H; Vicini L; Haig GM; Hunt T; Feltner D
    J Clin Psychopharmacol; 2006 Jun; 26(3):268-73. PubMed ID: 16702891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
    Griffiths RR; Bigelow GE; Liebson I; Kaliszak JE
    J Pharmacol Exp Ther; 1980 Dec; 215(3):649-61. PubMed ID: 7441524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW; Volkerts ER; van Willigenburg AP
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.